Log In
Print
BCIQ
Print
Print this Print this
 

Niraparib (formerly MK-4827)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionOral poly(ADP-ribose) polymerase (PARP) inhibitor
Molecular Target Poly(ADP-ribose) polymerase (PARP)
Mechanism of ActionPoly(ADP-ribose) polymerase (PARP) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today